Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study

Autor: Mette Reilev, Per Damkier, Lotte Rasmussen, Morten Olesen, Martin Thomsen Ernst, Rikke Mie Rishøj, Morten Rix Hansen, Anne Broe, Alexander Steenberg Dastrup, Maja Hellfritzsch, Sidsel Arnspang, Anton Pottegård, Jesper Hallas

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 10 (2017)

Background: Some studies indicate a reduced risk of serious upper gastrointestinal bleeding (UGIB) for users of beta-blockers, but the association remains to be confirmed in larger studies and characterized with respect to differences among beta-bloc

Externí odkaz: https://doaj.org/article/f76651bb6dc84f01bd73ac7efeb479e5

Prenatal exposure to nitrofurantoin and risk of childhood leukaemia: A registry-based cohort study in four Nordic countries

Autor: Sarah Hjorth, Maarit K. Leinonen, Marie Hargreave, Hedvig Nordeng, Anne Broe, Ulrika Nörby, Caroline H. Hemmingsen, Anton Pottegård

Publikováno v: International Journal of Epidemiology

Background Studies have suggested increased risks of childhood leukaemia after prenatal exposure to antibiotics, particularly nitrofurantoin. However, these findings may be related to the underlying maternal infection. This multinational study aimed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff36f33a615e3f7174714231f53ae7e
https://doi.org/10.1093/ije/dyab219

Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions

Autor: Kasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, Anne Broe, Emelie Curovic Rotbain, Per Damkier, Anton Pottegård, Jacob Andersen, Mikkel Højlund, Morten Olesen, Lotte Rasmussen, Morten Rix Hansen, Martin Thomsen Ernst, Rikke Wesselhoeft, Daniel Pilsgaard Henriksen, Mette Reilev, Mette Bliddal, Jesper Hallas

Publikováno v: Kristensen, K B, Lund, L C, Jensen, P B, Broe, A, Rotbain, E, Damkier, P, Pottegård, A, Andersen, J H, Højlund, M, Olesen, M, Rasmussen, L, Hansen, M R, Ernst, M T, Wesselhoeft, R, Henriksen, D P, Reilev, M, Bliddal, M & Hallas, J 2022, ' Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions ', Clinical Epidemiology, vol. 14, pp. 567-579 . https://doi.org/10.2147/CLEP.S353398

Kasper Bruun Kristensen,1 Lars Christian Lund,1 Peter Bjødstrup Jensen,1 Anne Broe,1 Emelie Rotbain,2 Per Damkier,1,3,4 Anton Pottegård,1 Jacob Harbo Andersen,1 Mikkel Højlund,1,5 Morten Olesen,1 Lotte Rasmussen,1 Morten Rix Hansen,1,3,4 Mar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb0c65a648d133aefbd9597ce9899d7
https://pubmed.ncbi.nlm.nih.gov/35509520

Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin

Autor: Anne Broe, Morten Olesen, Tore Bjerregaard Stage, Anton Pottegård, Jesper Hallas, Daniel Pilsgaard Henriksen, Mette Bliddal, Kasper Bruun Kristensen, Zandra Nymand Ennis, Martin Thomsen Ernst, Lars Christian Lund, Maja Hellfritzsch, Per Damkier, Peter Bjødstrup Jensen

Publikováno v: Hellfritzsch, M, Lund, L C, Ennis, Z, Stage, T, Damkier, P, Bliddal, M, Jensen, P B, Henriksen, D, Ernst, M T, Olesen, M, Broe, A, Kristensen, K B, Hallas, J & Pottegård, A 2020, ' Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin ', Clinical Pharmacology & Therapeutics, vol. 107, no. 3, pp. 607-616 . https://doi.org/10.1002/cpt.1662

The antibiotics dicloxacillin and flucloxacillin induce cytochrome P450-dependent metabolism of warfarin. We explored the influence of these drug–drug interactions on the clinical effectiveness of warfarin therapy due to atrial fibrillation or hear

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c811204022463a3dc8422244ebc4b681
https://doi.org/10.1002/cpt.1662

Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia

Autor: Pär Karlsson, Anne Broe, Kari Furu, Carolyn E. Cesta, Silvia Segovia Chacón, Anders Engeland, Per Damkier, Helle Kieler

Publikováno v: Acta Obstetricia et Gynecologica Scandinavica
Cesta, C E, Segovia Chacón, S, Engeland, A, Broe, A, Damkier, P, Furu, K, Kieler, H & Karlsson, P 2021, ' Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia ', Acta Obstetricia et Gynecologica Scandinavica, vol. 100, no. 11, pp. 2111-2118 . https://doi.org/10.1111/aogs.14251

Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for treatment of female infertility

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbff5456b9069929f9a13ab28683d2b
https://hdl.handle.net/11250/2831774